Effect of H 2 treatment in a mouse model of rheumatoid arthritis‐associated interstitial lung disease
Terasaki Yasuhiro, Terasaki Mika, Kanazawa Satoshi, Kokuho Nariaki, Urushiyama Hirokazu, Kajimoto Yusuke, Kunugi Shinobu, Maruyama Motoyo, Akimoto Toshio, Miura Yoko, Igarashi Tsutomu, Ohsawa Ikuroh, Shimizu Akira · Journal of Cellular and Molecular Medicine · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Effect of H 2 treatment in a mouse model of rheumatoid arthritis‐associated interstitial lung disease” is organized in H2HUBB under the research focus hydrogen arthritis study 2019 yasuhiro. The publication is cited as Terasaki Yasuhiro, Terasaki Mika, Kanazawa Satoshi, Kokuho Nariaki, Urushiyama Hirokazu, Kajimoto Yusuke, Kunugi Shinobu, Maruyama Motoyo, Akimoto Toshio, Miura Yoko, Igarashi Tsutomu, Ohsawa Ikuroh, Shimizu Akira, Journal of Cellular and Molecular Medicine, 2019. This uncontrolled human study examined Effect of H 2 treatment in a mouse model of rheumatoid arthritis‐associated interstitial lung disease. The abstract describes Human participants. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen arthritis study 2019 yasuhiro overview
We used D1CC mice to analyse chronic lung fibrosis development and evaluate H treatment effects. Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.
Study design and hydrogen intervention
Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Mouse model. Blinding: Unknown. Control status: Unknown.
Delivery method: Other or not reported.
Reported findings and scientific interpretation
For this hydrogen arthritis study 2019 yasuhiro, the study record reports the following: No detailed finding statement was available for this record. Readers should consult the original publication before drawing conclusions.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.